FORT
WORTH, Texas, June 19,
2024 /PRNewswire/ -- VERTESS
(http://vertess.com), a leading healthcare mergers and acquisitions
(M&A) advisory firm, is pleased to announce the successful
completion of two pharmacy transactions in Q2.
Savage Family Pharmacy (https://www.savagerx.com), a
family-owned pharmacy serving the Pennsylvania community since 1922, was
acquired by a private buyer in May
2024. Savage was the second part of the transaction overseen
by VERTESS Managing Directors, Alan
Hymowitz and Anna Elliott.
The first part of the transaction closed in Q3 2023. Hymowitz and
Elliott are grateful for their client's patience and perseverance
through the transaction process. "We couldn't have asked for a more
cooperative client. He was responsive and helpful throughout
both processes and was, more importantly, focused on realizing the
best outcome for his business," stated Elliott.
Apex Infusion Pharmacy (https://apex-iv.com), a fast-growing
provider of ambulatory infusion therapy services based in
California, was purchased by FFL
Capital Partners (https://www.fflpartners.com/), a private equity
firm focused on middle-market technology and healthcare services.
Founded in 2006 and headquartered in Signal Hill, California, Apex Infusion
provides high-quality, reliable care to patients in the comfort of
their own homes or in ambulatory settings, with the goal of
achieving the best possible outcomes. Apex coordinates professional
interaction with our patient's physicians, nurses, and other
healthcare providers. They provide intravenous immunoglobulin,
specialty infusion, total parental nutrition, and other therapeutic
services. Apex currently operates 11 locations in
California. Alan Hymowitz was the Managing Director who
advised on this transaction, as well. He has several decades of
pharmacy experience after owning, operating, and selling his own
pharmacy, and now provides consulting and transactional advisory
services. "Apex has such a strong track record and leadership
team. It was truly a pleasure to find the right buyer who
could take the company forward into its next growth phase,"
commented Hymowitz.
For more information, please contact Vaughne Glennie at 379354@email4pr.com or
+1.520.395.0244.
About VERTESS
VERTESS is an international healthcare-focused Mergers &
Acquisitions (M&A) advisory firm with expertise spanning
diverse healthcare and human service verticals, ranging from
behavioral health and intellectual/developmental disabilities to
DME, pharmacies, home care/hospice, urgent care, life sciences, and
other specialized services and products. Each VERTESS Managing
Director has had executive experience in either launching or
managing and ultimately successfully exiting a healthcare
company.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vertess-closes-two-pharmacy-deals-in-q2-302176286.html
SOURCE Vertess Healthcare Advisors, LLC